| Literature DB >> 29670312 |
Matthew Linger1, Jennifer Martin2.
Abstract
Keywords: Therapeutic Goods Administration; adverse effects; drug regulation; postmarket surveillance
Year: 2018 PMID: 29670312 PMCID: PMC5895470 DOI: 10.18773/austprescr.2018.010
Source DB: PubMed Journal: Aust Prescr ISSN: 0312-8008